Osteoprotegerin Before and After Periodontal Surgery

NCT02160613 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2014-06-10

No results posted yet for this study

Summary

The study hypothesis:

Is Osteoprotegerin a diagnostic and/or prognostic marker of periodontal disease?

Conditions

  • Chronic Periodontitis

Interventions

PROCEDURE

Open flap debridement

an access flap

Sponsors & Collaborators

  • Cairo University

    lead OTHER

Principal Investigators

  • Mahmoud ElRefai, M.D. · Professor of Oral Medicine and Periodontology , Faculty of oral and dental medicine Cairo Unv.

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
SINGLE
Model
SINGLE_GROUP

Eligibility

Min Age
32 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-04-30
Primary Completion
2013-12-31
Completion
2014-01-31

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02160613 on ClinicalTrials.gov